Biosimilars Congress next week brings news of new generic versions of Interferon, Filgrastim and Erythropoietin

Next week's London conference brings news from a company called Therapeutic Proteins, Ltd. (TPL), which claims to have developed new follow-on forms of these bio standards. -AMS